OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)
Clinical trial NCT04283227 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04283227
- Sponsor
- Orchard Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-17
- Primary completion
- 2026-01-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.